σ Receptor antagonists block the development of sensitization to cocaine
- 25 January 1996
- journal article
- Published by Elsevier BV in European Journal of Pharmacology
- Vol. 296 (2), 123-128
- https://doi.org/10.1016/0014-2999(95)00693-1
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- BMY 14802, a Sigma Receptor Ligand for the Treatment of SchizophreniaNeuropsychopharmacology, 1994
- Neuropharmacological profile of a novel and selective ligand of the sigma site: SR 31742ANeuropharmacology, 1993
- Behavioural and biochemical evidence of the interaction of the putative antipsychotic agent, BMY 14802 with the 5-HT1A receptorEuropean Journal of Pharmacology, 1991
- σ Receptors: From Molecule to ManJournal of Neurochemistry, 1991
- Selective σ ligands block stimulant effects of cocaineEuropean Journal of Pharmacology, 1991
- [3H]Ditolylguanidine binding to human brain σ sites is diminished after haloperidol treatmentEuropean Journal of Pharmacology, 1991
- Novel antipsychotic drugs share high affinity for σ receptorsEuropean Journal of Pharmacology, 1988
- Chronic amphetamine: Is dopamine a link in or a mediator of the development of tolerance and reverse tolerance?Pharmacology Biochemistry and Behavior, 1981
- Evolving Behavior in the Clinical and Experimental Amphetamine (Model) PsychosisAmerican Journal of Psychiatry, 1973
- Respiratory and subjective effects of d‐ and I‐pentazocineCancer Cell, 1968